This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Activity Details

645 * Thu, 8/5/2010, 10:30 AM - 12:20 PM CC-301 (West)
Key Multiplicity Issues in Clinical Trials — Invited Papers
Biopharmaceutical Section , Committee on Applied Statisticians , ENAR
Organizer(s): Alex Dmitrienko, Eli Lilly and Company
Chair(s): Yan Daniel Zhao, Eli Lilly and Company
10:35 AM Regulatory Considerations for Addressing Multiplicity Problems of Clinical Trials with Multiple Endpoints Mohammad F. Huque, FDA
11:00 AM Industry Perspective on the FDA Guidance on Multiplicity Issues Walter W. Offen, Eli Lilly and Company
11:25 AM Variations of and Types of Statistical Control for Multiplicity in Clinical Trials: The Academic Perspective Joseph Massaro, Boston University ; Ralph B. D'Agostino, Sr., Boston University
11:50 AM Multiplicity in Clinical Trials: A European Perspective Norbert Benda, BfArM ; Joachim Roehmel , Institute for Prevention Research and Social Medicine
12:15 PM Floor Discussion

2010 JSM Online Program Home

For information, contact or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.